| Q36824086 | A biologic basis for integrated malaria control |
| Q30000809 | A novel approach for measuring the burden of uncomplicated Plasmodium falciparum malaria: application to data from Zambia |
| Q60914449 | A probabilistic model of pre-erythrocytic malaria vaccine combination in mice |
| Q33939379 | A sub-microscopic gametocyte reservoir can sustain malaria transmission. |
| Q35746989 | Accuracy of an Immunochromatographic Diagnostic Test (ICT Malaria Combo Cassette Test) Compared to Microscopy among under Five-Year-Old Children when Diagnosing Malaria in Equatorial Guinea. |
| Q24651173 | Acquired immunity to malaria |
| Q35910858 | Asymptomatic Plasmodium falciparum infections may not be shortened by acquired immunity |
| Q33385921 | Atypical aetiology of a conjugal fever: autochthonous airport malaria between Paris and French Riviera: a case report |
| Q36391845 | Can growth inhibition assays (GIA) predict blood-stage malaria vaccine efficacy? |
| Q90341629 | Cerebral Plasmodium falciparum malaria: The role of PfEMP1 in its pathogenesis and immunity, and PfEMP1-based vaccines to prevent it |
| Q36433138 | Characterization of the infectious reservoir of malaria with an agent-based model calibrated to age-stratified parasite densities and infectiousness |
| Q36791096 | Competition for red blood cells can enhance Plasmodium vivax parasitemia in mixed-species malaria infections. |
| Q36288932 | Competitive release and facilitation of drug-resistant parasites after therapeutic chemotherapy in a rodent malaria model |
| Q38001604 | Controlled human blood stage malaria infection: current status and potential applications |
| Q42362303 | Development of new malaria diagnostics: matching performance and need. |
| Q40758211 | Diarylheptanoids Rich Fraction of Alnus nepalensis Attenuates Malaria Pathogenesis: In-vitro and In-vivo Study |
| Q33791653 | Effectiveness of reactive case detection for malaria elimination in three archetypical transmission settings: a modelling study |
| Q40496261 | Evaluating malaria attributable morbidity in endemic areas |
| Q35152209 | Exposure-dependent control of malaria-induced inflammation in children |
| Q36503207 | Factors determining the occurrence of submicroscopic malaria infections and their relevance for control |
| Q36790241 | Gametocytemia and fever in human malaria infections |
| Q30665506 | Genesis, sequestration and survival of Plasmodium falciparum gametocytes: parameter estimates from fitting a model to malariatherapy data |
| Q28551653 | Hitting a Moving Target: A Model for Malaria Elimination in the Presence of Population Movement |
| Q36953344 | Host immune constraints on malaria transmission: insights from population biology of within-host parasites |
| Q92463531 | How delayed and non-adherent treatment contribute to onward transmission of malaria: a modelling study |
| Q55265346 | How long do rapid diagnostic tests remain positive after anti-malarial treatment? |
| Q39932709 | How selection forces dictate the variant surface antigens used by malaria parasites |
| Q37444728 | Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance |
| Q38728601 | Immune activation and induction of memory: lessons learned from controlled human malaria infection with Plasmodium falciparum |
| Q34870862 | Link between immune response and parasite synchronization in malaria |
| Q36568243 | Malaria parasite diversity and transmission intensity affect development of parasitological immunity in a mathematical model |
| Q39650544 | Malaria rapid diagnostic tests: one size may not fit all. |
| Q32128675 | Malaria therapy reinoculation data suggest individual variation of an innate immune response and independent acquisition of antiparasitic and antitoxic immunities |
| Q36030583 | Marked Rise in the Prevalence of Asymptomatic Plasmodium falciparum Infection in Rural Gabon |
| Q34217648 | Mathematical modeling of malaria infection with innate and adaptive immunity in individuals and agent-based communities. |
| Q37119364 | Mathematical models of within-host and transmission dynamics to determine effects of malaria interventions in a variety of transmission settings |
| Q45127887 | Mechanisms of transfusion-linked parasite infection |
| Q46827107 | Misinformation and misbeliefs in the Tuskegee Study of Untreated Syphilis fuel mistrust in the healthcare system. |
| Q35984759 | Modelling the dynamics of Plasmodium falciparum histidine-rich protein 2 in human malaria to better understand malaria rapid diagnostic test performance. |
| Q28474141 | Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity |
| Q33960088 | Monitoring, characterization and control of chronic, symptomatic malaria infections in rural Zambia through monthly household visits by paid community health workers |
| Q35771770 | Mosquito infection studies with Aotus monkeys and humans infected with the Chesson strain of Plasmodiun vivax |
| Q31002453 | Onset of clinical immunity toPlasmodium falciparumamong Javanese migrants to Indonesian Papua |
| Q34427744 | P. falciparum infection durations and infectiousness are shaped by antigenic variation and innate and adaptive host immunity in a mathematical model |
| Q36791350 | Parasite prevalence: a static measure of dynamic infections |
| Q91719970 | Peptide-Based Vaccines: Current Progress and Future Challenges |
| Q36790116 | Plasmodium malariae blood-stage dynamics |
| Q36824079 | Plasmodium malariae infection boosts Plasmodium falciparum gametocyte production. |
| Q36824070 | Plasmodium vivax blood-stage dynamics |
| Q35842716 | Predicting the impact of border control on malaria transmission: a simulated focal screen and treat campaign |
| Q31002463 | Primary infection by Plasmodium falciparum or P. vivax in a cohort of Javanese migrants to Indonesian Papua. |
| Q44141909 | Problems with continuous-time malaria models in describing gametocytogenesis |
| Q44148061 | Random, top-down, or bottom-up coexistence of parasites: malaria population dynamics in multi-parasitic settings |
| Q33910163 | Resisting and tolerating P. falciparum in pregnancy under different malaria transmission intensities |
| Q36791360 | Strain theory of malaria: the first 50 years |
| Q47925325 | Subpatent infection with nucleoside transporter 1-deficient Plasmodium blood stage parasites confers sterile protection against lethal malaria in mice |
| Q42127731 | Substantially reduced pre-patent parasite multiplication rates are associated with naturally acquired immunity to Plasmodium falciparum |
| Q35134453 | Switching rates of Plasmodium falciparum var genes: faster than we thought? |
| Q24644343 | The impact of malaria parasitism: from corpuscles to communities |
| Q38196455 | The path of malaria vaccine development: challenges and perspectives |
| Q37751651 | The selection landscape of malaria parasites. |
| Q64104328 | The temporal dynamics and infectiousness of subpatent Plasmodium falciparum infections in relation to parasite density |
| Q34806993 | Towards a comprehensive simulation model of malaria epidemiology and control. |
| Q34023865 | Towards malaria elimination in Mpumalanga, South Africa: a population-level mathematical modelling approach |
| Q47594749 | Towards malaria elimination in Savannakhet, Lao PDR: mathematical modelling driven strategy design |
| Q35541802 | Utilization of genomic sequence information to develop malaria vaccines |
| Q37145544 | Virulence evolution in response to vaccination: the case of malaria |
| Q35213982 | Virulence in malaria: an evolutionary viewpoint |
| Q37426820 | World Malaria Day 2009: what malaria knows about the immune system that immunologists still do not. |